Artificial intelligence vendor DiA has emerged as a key third-party provider of AI to larger imaging vendors.

The key interventional cardiology takeaways from sessions presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2022 annual meeting.

A new study reveals the damage caused to cardiovascular programs by the COVID-19 pandemic will continue to accrue unless mitigation strategies are implemented quickly. The review found a number of people dying are at home from heart conditions. 

Brian Ghoshhajra, MD, MBA, division chief, cardiovascular imaging, Massachusetts General Hospital and associate professor of radiology, Harvard Medical School, and a board member of the Society of cardiovascular Computed Tomography (SCCT), explains the rapidly expanding interest in cardiac computed tomography (CT) under the new chest pain evaluation guidelines.

Researchers also noted that uncontrolled hypertension, exposure to second-hand smoke and untreated type 2 diabetes were all associated with a greater rupture risk.

When cocaine users are hospitalized for heart failure, what should physicians expect? Are beta-blockers an effective treatment strategy? 

Brian Ghoshhajra, MD, MBA, division chief, cardiovascular imaging, Massachusetts General Hospital and associate professor of radiology, Harvard Medical School, explains the impact of the iodine contrast shortage on computed tomography (CT) and cardiac imaging.
 

Dozens of customers have reported issues with the device’s balloon or catheter hub separating from the delivery system, mostly during off-label use in a patient's blood vessels.

Researchers aimed to shine light on this key topic, tracking data from nearly 200,000 patients. 

The collaboration is aimed at improving patient outcomes after cardiac surgeries and other procedures.